AI Integration for Clinical Trial Endpoint Adjudication

AI integration for endpoint adjudication connects to the Electronic Data Capture (EDC) system—such as Medidata Rave or Oracle Clinical—and vendor systems for imaging (PACS) and labs (LIMS). The AI agent is triggered when a potential endpoint event is recorded, automatically retrieving the associated patient medical records, imaging studies, lab reports, and source documents from connected systems via APIs or clinical data warehouses. It processes this unstructured data to extract relevant findings, timelines, and measurements against the protocol-defined endpoint criteria.

The core workflow involves the AI generating a structured adjudication packet summary, which includes a preliminary assessment of whether the evidence meets the endpoint definition, highlights conflicting data, and flags missing documentation. This packet is then routed into the adjudication committee workflow within the Clinical Trial Management System (CTMS) or a dedicated adjudication platform. Committee members review the AI-summarized case instead of raw documents, focusing their expertise on interpretation and final vote. This reduces manual evidence compilation from hours to minutes per case and standardizes the initial data review.

Governance is critical. The AI's role is assistive, not determinative; all final decisions remain with the committee. The system maintains a full audit trail, linking source data to AI-generated summaries and committee votes. Implementations typically start with a parallel review pilot, where the AI's summaries are compared to traditional manual reviews to validate accuracy and refine prompts before full rollout. This approach ensures regulatory compliance while delivering operational efficiency, allowing committees to handle higher case volumes and reduce time to database lock.

The integration connects to primary data sources—typically the Electronic Data Capture (EDC) system (e.g., Medidata Rave, Oracle Clinical) for case report forms, a medical imaging archive (PACS/VNA) for DICOM studies, and often a Laboratory Information Management System (LIMS) for lab data. An orchestration agent, triggered by a new adjudication event in the CTMS or EDC, uses secure APIs and HL7/FHIR interfaces to retrieve and pseudonymize the relevant patient records, imaging series, and lab reports for a specific endpoint. This raw data is staged in a secure, temporary processing environment.

A multi-step AI pipeline then processes the collated case file: a document intelligence model extracts key findings from clinical notes and lab PDFs; a computer vision agent analyzes relevant imaging slices, flagging potential anomalies and generating a structured radiology summary; and a temporal reasoning layer sequences events from the EDC data. These outputs are synthesized into a unified adjudication briefing packet—a structured JSON summary with supporting evidence citations—which is posted back to the adjudication committee workflow module within the CTMS (e.g., Veeva Vault CTMS) or a dedicated review platform. The briefing pre-populates the case review form, highlighting concordant data, flagging discrepancies for human attention, and suggesting potential adjudication outcomes based on protocol criteria.

Governance is designed into the flow: all AI-generated content is watermarked and logged with a full audit trail linking back to source system queries. The system operates in a human-in-the-loop mode; the committee makes the final determination, but with review time cut from hours to minutes per case. Rollout follows a phased validation, starting with a parallel shadow mode where AI briefings are compared to manual preparations for a subset of endpoints, ensuring accuracy and building trust before enabling direct workflow integration.

Integrating AI into endpoint adjudication requires a governance-first architecture that preserves the committee's ultimate authority. The AI agent acts as a pre-review assistant, analyzing source documents—medical records, imaging reports, and lab data from the EDC (e.g., Medidata Rave) and connected vendor systems—to generate a structured case summary. This summary, along with key excerpts and a confidence score, is presented within the committee's existing workflow interface (often a specialized module or portal). All AI interactions, prompts, and source data citations are logged to an immutable audit trail linked to the patient case ID and adjudication event in the clinical database.

A phased rollout is critical for adoption and validation. Start with a parallel review pilot: for a subset of cases, the AI generates its summary while the committee conducts its standard review, allowing for comparison and tuning without impacting timelines. Phase two introduces AI-assisted triage, where the system prioritizes cases for committee review based on complexity or data discrepancies flagged against the protocol. The final phase enables AI-drafted adjudication forms, where the system pre-populates the committee's decision template with proposed findings, which the medical monitor and committee members edit and approve. Throughout, role-based access controls (RBAC) ensure only authorized users (e.g., committee chairs, medical monitors) can view AI outputs and override suggestions.

Compliance is engineered into the data flow. The AI system only accesses de-identified patient data as permitted by the study protocol, and all data processing occurs within the sponsor's or CRO's secure cloud environment. Model outputs are validated against a golden set of historical adjudication decisions to monitor for drift, and a human-in-the-loop approval step is mandatory before any AI-generated content is committed to the trial's permanent regulatory records. This approach turns AI from a black box into a governed, traceable component of the clinical evidence generation process.